In our previous laboratory investigations, we have observed that the combination therapy of NAC and insulin exhibits superior efficacy in managing various complications associated with T1DM, including cardiomyopathy, hepatic disorders, and renal dysfunction when compared to insulin monotherapy [24,25,26]. The gene discussed is INS; the disease is type 1 diabetes mellitus.